Close



Nov 13, 2017 05:45AM
Nov 10, 2017 05:05PM
Oct 13, 2017 09:30AM
Oct 13, 2017 07:57AM
Oct 13, 2017 06:14AM
Oct 13, 2017 06:07AM
Oct 12, 2017 04:52PM Spark Therapeutics (ONCE) Confirms FDA Advisory Committee Unanimously Recommended Approval of LUXTURNA for Patients with Biallelic RPE65-mediated IRD
Oct 12, 2017 04:51PM
Oct 12, 2017 07:30AM
Oct 10, 2017 09:30AM
Aug 2, 2017 09:24AM
Aug 2, 2017 07:30AM
Jul 31, 2017 07:32AM
Jul 31, 2017 07:30AM Spark Therapeutics Submits Marketing Authorization Application to European Medicines Agency for Investigational LUXTURNA™ (voretigene neparvovec)
Jul 20, 2017 07:36AM
Jul 20, 2017 07:30AM
Jul 17, 2017 07:31AM
Jul 17, 2017 07:30AM

12,341 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All